Published in Cochrane Database of Systematic Reviews · View the paper (DOI)
A systematic review by ISGlobal found mefloquine to be more effective than SP and cotrimoxazole in reducing parasite levels and anemia in pregnant women. However, it was less well tolerated, with higher risks of adverse events such as vomiting, fatigue, and dizziness
Coverage from 3 institutions
- Mefloquine effectively prevents malaria during pregnancy but is not well tolerated Barcelona Institute for Global Health (ISGlobal) · Apr 5, 2018 · first to report
- Ready to quit vaping in the new year? A new study uncovers the best ways University of Massachusetts Amherst · Jan 7, 2025
- Financial incentives found to help people quit smoking, including during pregnancy University of Massachusetts Amherst · Jan 12, 2025